Cates Daniel J, Evangelista Lisa M, Belafsky Peter C
Department of Otolaryngology-Head and Neck Surgery, University of California-Davis, Sacramento, California, USA.
Otolaryngol Head Neck Surg. 2022 Mar;166(3):506-510. doi: 10.1177/01945998211009853. Epub 2021 May 4.
Chemoradiation therapy (CRT) for head and neck cancer can have profound effects on swallowing function. Identification of risk factors for development of swallowing dysfunction after CRT may improve allocation of preventive strategies. The purpose of this study is to determine the association between pre-CRT dysphagia and post-CRT swallowing dysfunction.
Retrospective cohort study.
Academic medical center.
Patients with head and neck cancer were evaluated before and 3 months after CRT. Dysphagia was assessed with the Eating Assessment Tool (EAT-10). Swallowing dysfunction was evaluated by a videofluoroscopic swallow study and the Penetration-Aspiration Scale and swallowing safety was evaluated by the Functional Oral Intake Scale. The association between pre-CRT EAT-10 scores and post-CRT swallowing dysfunction was evaluated.
The mean ± SD post-CRT Functional Oral Intake Scale score was 6.5 ± 1.2 for individuals with a pre-CRT EAT-10 score <3 and 5.3 ± 1.9 for those with a pre-CRT EAT-10 score ≥3 ( < .001). The mean post-CRT Penetration-Aspiration Scale score was 2.2 ± 1.5 for individuals with a pre-CRT EAT-10 score <3 and 3.8 ± 2.6 for those with a pre-CRT EAT-10 score ≥3 ( < .001). After multivariate analysis adjusting for age, tumor subsite, T classification, and primary surgery, pre-CRT dysphagia (EAT-10 ≥3) was an independent predictor of post-CRT aspiration (odds ratio, 4.19 [95% CI, 1.08-16.20]; = .04) and feeding tube dependence (odds ratio, 3.54 [95% CI, 1.01-12.33]; = .04).
The presence of dysphagia before chemoradiation for head and neck cancer is an independent predictor of swallowing dysfunction after completion of therapy. These results may help target intervention toward preventing swallowing dysfunction in high-risk individuals.
头颈部癌的放化疗(CRT)可对吞咽功能产生深远影响。识别CRT后吞咽功能障碍发生的风险因素可能会改善预防策略的分配。本研究的目的是确定CRT前吞咽困难与CRT后吞咽功能障碍之间的关联。
回顾性队列研究。
学术医疗中心。
对头颈部癌患者在CRT前和CRT后3个月进行评估。使用饮食评估工具(EAT-10)评估吞咽困难。通过电视荧光吞咽造影研究和渗透-误吸量表评估吞咽功能障碍,并通过功能性经口摄食量表评估吞咽安全性。评估CRT前EAT-10评分与CRT后吞咽功能障碍之间的关联。
CRT前EAT-10评分<3的个体,CRT后功能性经口摄食量表平均评分±标准差为6.5±1.2,而CRT前EAT-10评分≥3的个体为5.3±1.9(P<.001)。CRT前EAT-10评分<3的个体,CRT后渗透-误吸量表平均评分为2.2±1.5,而CRT前EAT-10评分≥3的个体为3.8±2.6(P<.001)。在对年龄、肿瘤亚部位、T分类和初次手术进行多因素分析后,CRT前吞咽困难(EAT-10≥3)是CRT后误吸(比值比,4.19[95%CI,1.08-16.20];P=.04)和鼻饲管依赖(比值比,3.54[95%CI,1.01-12.33];P=.04)的独立预测因素。
头颈部癌放化疗前存在吞咽困难是治疗完成后吞咽功能障碍的独立预测因素。这些结果可能有助于针对高危个体预防吞咽功能障碍进行干预。